Dima Pukhov

Solo Angel San Francisco, United States

Dima Pukhov invests in early-stage founders across diverse industries, with a particular interest in EdTech, SaaS, and Marketplaces. They are cautious about the unnecessary use of AI in pitches.

About Dima Pukhov

Dima Pukhov appears in the source data as an individual angel investor with a LinkedIn profile but no website, Crunchbase entry, or disclosed thesis, stage, sector, or check size. This is a thin profile typical of operator-angels who invest small checks opportunistically based on personal interest, professional network, and referral relationships. For healthcare AI founders, the realistic expectation is a small angel check, likely in the $5K to $50K range, with no thesis-specific healthcare alignment unless surfaced through direct conversation. Founders should not expect Pukhov to play a meaningful role in a primary venture round; the value, if any, is likely operational advice or network introductions if his background is relevant to your category. The cleanest entry path is direct LinkedIn outreach with a short, specific note that does not assume he invests in healthcare and explicitly asks about his check capacity, recent investments, and areas of interest before any pitch preparation. Founders should pre-qualify by checking the LinkedIn profile for current and prior roles, geographic location, and any signals of healthcare or AI experience. If his background is in adjacent fields like fintech, consumer tech, or general SaaS rather than healthcare, the probability of a productive engagement is low. Be honest about the asymmetry: at this profile, founder time investment should be capped at a brief outreach and one short call if interest surfaces. Founders with limited fundraising bandwidth should prioritize disclosed-thesis investors and meaningful angels with healthcare track records first, treating Pukhov as a low-effort incremental outreach rather than a strategic target.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Dima Pukhov

Tools made by companies in Dima Pukhov's portfolio that we cover in the directory.

Tempus ECG-Low EF
Tempus
Cardiology AI
Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation.
xT CDx
Tempus
Lab & Diagnostics
Tempus xT CDx is an FDA-approved, 648-gene Next Generation Sequencing (NGS) test for comprehensive molecular profiling of solid malignant tumors, including companion diagnostic claims for colorectal cancer.
Study Watch with Irregular Pulse Monitor
Verily Life Sciences
Cardiology AI
The Verily Study Watch with Irregular Pulse Monitor is an FDA-cleared, prescription-only wearable device from Verily Life Sciences. It is designed for adult patients (22+) to monitor and record single-channel ECG rhythms and detect irregular pulses indicative of atrial fibrillation, primarily for use in clinical research and professional healthcare settings.
Study Watch
Verily
Cardiology AI
Verily Study Watch is a prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform.
Study Watch with Irregular Pulse Monitor (Home)
Verily Health
Cardiology AI
The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics.
AISight Dx
PathAI
Pathology AI
AISight Dx is PathAI's FDA-cleared, cloud-native digital pathology image management system that integrates AI algorithms to support laboratory workflows, clinical operations, and primary diagnosis in the US. It streamlines diagnostic workflows, enables precision collaboration, and supports accurate, efficient diagnoses across various settings.
AI Workbench
Deep Genomics
Drug Discovery & Research
Deep Genomics is an AI-driven drug discovery company that decodes RNA biology to find novel targets, mechanisms, and molecules for RNA-based drug candidates, focusing on genetic diseases.
Freenome
Freenome
Clinical Decision Support & Reference
Freenome develops AI-powered, blood-based screening tests for early cancer detection using multiomics technology.

Portfolio companies in our directory

Legion
Practice Management Suite
San Francisco, CA
1 tool in directory
$50M–$250M
Legion is an AI-powered workforce management platform designed to optimize labor efficiency and employee engagement, particularly relevant for…
Deep Genomics
AI Research Lab Biotech / Drug Discovery
Toronto, Canada
1 tool in directory
$50M–$250M
Deep Genomics is a leading artificial intelligence (AI) therapeutics company that is revolutionizing drug discovery and development for…
Drug Discovery & Research
Freenome
Biotech / Drug Discovery Point-of-Care Diagnostics
Brisbane, CA
1 tool in directory
$250M+
Freenome is a biotechnology company focused on revolutionizing cancer detection through its multiomics platform and artificial intelligence (AI).…
Clinical Decision Support & Reference Lab & Diagnostics
PathAI
Biotech / Drug Discovery Point-of-Care Diagnostics
Boston, MA
1 tool in directory
$250M+
PathAI is a leading healthcare AI company focused on transforming pathology through the application of artificial intelligence. For…
Pathology AI
Tempus
Biotech / Drug Discovery Clinical AI Platform
Chicago, Illinois, U.S.
2 tools in directory
$250M+
Tempus is a healthcare technology company that leverages artificial intelligence to advance precision medicine. The company has built…
Verily Life Sciences
Clinical AI Platform Healthcare Analytics / BI
Dallas, Texas [1, 3, 4, 15, 17]
2 tools in directory
$250M+
Verily Life Sciences, now officially known as Verily Health Inc. as of March 2026, is a precision health…
Cardiology AI Wearables & Remote Monitoring (RPM)

Team

Dima Pukhov
Founder

Pitch / review this investor

Have you raised from Dima Pukhov? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.